
September 10, 2015 Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin

September 10, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing apps, healthcare mobility, market report, mobile healthcare, smartphones

September 9, 2015 Medical Communications, Research and Development Dr Michael Koslowski, Mission Therapeutics
September 8, 2015 Medical Communications Biocair

September 8, 2015 Medical Communications, Research and Development, Sales and Marketing Roche, Scotland, avastin, ovarian cancer

September 8, 2015 Medical Communications Mehwish Abdeali, wave

September 4, 2015 Medical Communications, Sales and Marketing CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, cuts

September 3, 2015 Medical Communications Jeremy Hunt, NHS, data protection, digital technology, george freeman

September 2, 2015 Medical Communications EU, European Commission, TTIP, drug policy, lobbying, transparency

September 1, 2015 Medical Communications Andy Conrad, Google life sciences, Sanofi, Type 1 diabetes, diabetes, google, type 2 diabetes

September 1, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, benefit-risk analysis, pharmacoepidemiology, pharmacovigilance

August 28, 2015 Medical Communications, Research and Development Mytrus, NHS, clinical trials, digital health technology, electronic informed consent

August 28, 2015 Medical Communications, Research and Development Amgen, FDA, Repatha, evolocumab

August 28, 2015 Medical Communications Communication, apps, digital, medcomms, medical communications, mobile

August 28, 2015 Medical Communications, Research and Development ALN-PCScs, Repatha, alirocumab, cardiology, cardiovascular disease, cvd, evolocumab, heart disease, high cholesterol, praluent